Legal Opinion

In re Vicuron Pharmaceuticals, Inc. Securities Litigation

District Court, E.D. Pennsylvania

Decided October 7, 2004No. CIV.A. 04-2627PublishedCited by 27 opinions

1Opinion of the Court

MEMORANDUM

BARTLE, District Judge.

Before the court are four motions for appointment of lead plaintiff and approval of lead counsel in this consolidated putative class action securities litigation1 brought under §§ 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995 (“PSLRA”), 15 U.S.C. §§ 78j(b) and 78t, and Rule 10b-5 promulgated thereunder, 17 C.F.R. § 240.10b-5. The motions have been filed by the following individuals or groups: (1) Bulmaro Vasquez, Michael Epstein, James New, and John Taylor (“Vasquez Group”); (2)…

2Cases cited4 opinions

  1. In Re: Cendant Corporation LitigationCourt of Appeals for the Third Circuit · 1992
  2. Hassine v. JeffesCourt of Appeals for the Third Circuit · 1988
  3. In re Oxford Health Plans Inc., Securities LitigationDistrict Court, S.D. New York · 1998
  4. In re Cell Pathways, Inc., Securities Litigation IIDistrict Court, E.D. Pennsylvania · 2001

3Cited by27 opinions

  1. Kaplan v. GelfondDistrict Court, S.D. New York · 2007
  2. Foley v. Transocean Ltd.District Court, S.D. New York · 2011
  3. In re Gentiva Securities LitigationDistrict Court, E.D. New York · 2012
  4. In re Cardinal Health, Inc.District Court, S.D. Ohio · 2005
  5. City of Monroe Employees' Retirement System v. Hartford Financial Services Group, Inc.District Court, S.D. New York · 2010

22 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API